journal article·2025-10Open access

Enhancing compliance and extracellular matrix properties of tissue-engineered vascular grafts through pulsatile bioreactor culture

Angus Weekes, Jordan W. Davern, Nigel Pinto, Jason Jenkins, Zhiyong Li, Christoph Meinert, Travis J. Klein

Abstract

Biofabrication techniques represent a promising avenue for the production of small diameter vascular grafts. However, while current tissue-engineered vascular grafts (TEVGs) fulfil certain functional requirements of native blood vessels, most exhibit very poor mechanical compliance, directly reducing patency in vivo. Here, highly compliant TEVGs were cultured in a dynamic pulsatile bioreactor which ensured enhanced compliance, using biomimetic melt electrowritten (MEW) tubular scaffolds as substrates for tissue growth. Through 6-week in vitro culture, we investigated differences in extracellular matrix (ECM) production and mechanical performance of TEVGs cultured with placental mesenchymal stem cells (MSCs) and smooth muscle cells (SMCs) in static and dynamic conditions. Pulsatile stimulation successfully maintained the high compliance (12.4 ± 0.8 % per 100 mmHg) of our biomimetic scaffolds, substantially greater than existing small diameter grafts. Dynamic TEVGs demonstrated physiologically relevant burst pressure (1125 ± 212 mmHg) and suture pull-out force (3.0 ± 0.4 N), while also accumulating greater ECM components than static TEVGs. To assess off-the-shelf suitability, grafts were decellularized and lyophilised to produce d-TEVGs, which exhibited negligible loss of mechanics or ECM integrity. Finally, rehydrated d-TEVGs were seeded with endothelial cells in vitro, with an intimal endothelial lining forming after 7 days. These findings demonstrate the production of TEVGs with specifically engineered mechanical compliance which has been maintained by dynamic in vitro culture, supporting continued work toward biofabrication of the next generation of vascular grafts.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Walpoth · 2020
2. Development of a novel hierarchically biofabricated blood vessel mimic decorated with three vascular cell populations for the reconstruction of small-diameter arteries
3. Future perspectives in small-diameter vascular graft engineering10.3390/bioengineering7040160 ↗
4. Biofabrication of small diameter tissue-engineered vascular grafts10.1016/j.actbio.2021.11.012 ↗
5. Biaxial stretch improves elastic fiber maturation, collagen arrangement, and mechanical properties in engineered arteries10.1089/ten.tec.2015.0309 ↗
6. Current understanding of intimal hyperplasia and effect of compliance in synthetic small diameter vascular grafts10.1039/D0BM00226G ↗
7. Physiological pulsatile flow culture conditions to generate functional endothelium on a sulfated silk fibroin nanofibrous scaffold10.1016/j.biomaterials.2014.02.050 ↗
8. A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells10.1016/j.biomaterials.2009.09.086 ↗
9. Vascular mechanobiology: towards control of in situ regeneration10.3390/cells6030019 ↗
10. Biomimetic approaches in scaffold-based blood vessel tissue engineering10.3390/biomimetics9070377 ↗
11. U.S. Food and Drug Administration · 2024
12. Humacyte Inc
13. Food
14. Food · 2024
15. Allogeneic human tissue-engineered blood vessel
16. Improving in vivo outcomes of decellularized vascular grafts via incorporation of a novel extracellular matrix10.1016/j.biomaterials.2017.06.025 ↗
17. Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation10.1126/scitranslmed.aau6934 ↗
18. Implantable tissue-engineered blood vessels from human induced pluripotent stem cells10.1016/j.biomaterials.2016.06.010 ↗
19. Design, preparation, and performance of a novel bilayer tissue-engineered small-diameter vascular graft10.1002/mabi.201800189 ↗
20. A novel strategy to engineer small-diameter vascular grafts from marrow-derived mesenchymal stem cells10.1111/j.1525-1594.2011.01231.x ↗
21. Current biofabrication methods for vascular tissue engineering and an introduction to biological textiles10.1088/1758-5090/acbf7a ↗
22. Stem cell sources for vascular tissue engineering and regeneration10.1089/ten.teb.2011.0264 ↗
23. In vivo functional evaluation of tissue-engineered
24. Small-diameter vascular tissue engineering10.1038/nrcardio.2013.77 ↗
25. Vascular tissue engineering: progress, challenges, and clinical promise10.1016/j.stem.2018.02.009 ↗
26. The tissue-engineered vascular graft - past, present, and future10.1089/ten.teb.2015.0100 ↗
27. Decellularized blood vessel development: current state-of-the-art and future directions
28. Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation10.1126/scitranslmed.aau6934 ↗
29. Arterial reconstruction with human bioengineered acellular blood vessels in patients with peripheral arterial disease10.1016/j.jvs.2019.11.056 ↗
30. Tissue engineered human acellular blood vessels for coronary artery bypass grafting10.1161/res.131.suppl_1.P1017 ↗
31. Vascular tissue engineering: polymers and methodologies for small caliber vascular grafts10.3389/fcvm.2020.592361 ↗
32. ECM roles and biomechanics in cardiac tissue decellularization10.1152/ajpheart.00372.2022 ↗
33. An overview of tissue and whole organ decellularization processes10.1016/j.biomaterials.2011.01.057 ↗
34. Characterization of a heparinized decellularized scaffold and its effects on mechanical and structural properties10.1080/09205063.2020.1736741 ↗
35. Tissue engineering by decellularization and 3D bioprinting10.1016/j.mattod.2016.12.005 ↗
36. Strategies for tissue and organ decellularization10.1002/jcb.24130 ↗
37. In vivo performance of decellularized vascular grafts: a review article10.3390/ijms19072101 ↗
38. Small-diameter decellularized vascular graft with electrospun polycaprolactone10.1016/j.matlet.2020.128973 ↗
39. Vitrified human umbilical arteries as potential grafts for vascular tissue engineering10.1007/s13770-020-00243-x ↗
40. Moffat · 2022
41. Decellularization strategies for regenerative medicine: from processing techniques to applications10.1155/2017/9831534 ↗
42. Decellularized native and engineered arterial scaffolds for transplantation10.3727/000000003108747136 ↗
43. Highly compliant biomimetic scaffolds for small diameter tissue-engineered vascular grafts (TEVGs) produced via melt electrowriting (MEW)
44. Peripheral blood derived endothelial colony forming cells as suitable cell source for pre-endothelialization of arterial vascular grafts under dynamic flow conditions10.1016/j.mvr.2022.104402 ↗
45. Mesenchymal stem/stromal cells enhance engraftment, vasculogenic and pro-angiogenic activities of endothelial colony forming cells in immunocompetent hosts10.1038/s41598-017-13971-3 ↗
46. Harnessing the regenerative potential of fetal mesenchymal stem cells and endothelial colony-forming cells in the biofabrication of tissue-engineered vascular grafts (TEVGs)10.1155/2024/8707377 ↗
47. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality10.1634/stemcells.20-6-530 ↗
48. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice10.1073/pnas.0508945102 ↗
49. High-yield isolation of pure fetal endothelial colony forming cells and mesenchymal stem cells from the human full-term placenta
50. Novel isolation strategy to deliver pure fetal-origin and maternal-origin mesenchymal stem cell (MSC) populations from human term placenta10.1016/j.placenta.2014.09.001 ↗
51. Prospective surface marker-based isolation and expansion of fetal endothelial colony-forming cells from human term placenta10.5966/sctm.2013-0092 ↗
52. The British Standards Institution · 2017
53. Comparison of the direct burst pressure and the ring tensile test methods for mechanical characterization of tissue-engineered vascular substitutes10.1016/j.jmbbm.2014.02.017 ↗
54. Comprehensive mechanical characterization of PLA fabric combined with PCL to form a composite structure vascular graft10.1016/j.jmbbm.2016.11.005 ↗
55. Evaluation of the probe burst test as a measure of strength for a biologically-engineered vascular graft10.1016/j.jmbbm.2021.104527 ↗
56. McDowell · 2021 · 11 · 969
57. Fiji: an open-source platform for biological-image analysis10.1038/nmeth.2019 ↗
58. Tissue engineering of blood vessels: functional requirements, progress, and future challenges10.1007/s13239-011-0049-3 ↗
59. Indirect burst pressure measurements for the mechanical assessment of biological vessels10.1089/ten.tec.2019.0133 ↗
60. Human tissue-engineered blood vessels for adult arterial revascularization10.1038/nm1364 ↗
61. Current strategies for the manufacture of small size tissue engineering vascular grafts10.3389/fbioe.2018.00041 ↗
62. The evolution of vascular tissue engineering and current state of the art10.1159/000331406 ↗
63. From arteries to capillaries: approaches to engineering human vasculature
64. Nonlinear elasticity of blood vessels and vascular grafts10.1021/acsbiomaterials.4c00326 ↗
65. In vivo evaluation of compliance mismatch on intimal hyperplasia formation in small diameter vascular grafts10.1039/D3BM00167A ↗
66. Readily available tissue-engineered vascular grafts10.1126/scitranslmed.3001426 ↗
67. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery10.1016/j.biomaterials.2008.11.011 ↗
68. Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery10.1089/ten.tea.2013.0550 ↗
69. Engineering small-caliber vascular grafts from collagen filaments and nanofibers with comparable mechanical properties to native vessels10.1088/1758-5090/ab15ce ↗
70. Melt electrowritten scaffold architectures to mimic tissue mechanics and guide neo-tissue orientation10.1016/j.jmbbm.2023.106292 ↗
71. Morphologic and mechanical characteristics of engineered bovine arteries10.1067/mva.2001.111747 ↗
72. Compliance properties of conduits used in vascular reconstruction10.1046/j.1365-2168.2000.01566.x ↗
73. An integrated design, material, and fabrication platform for engineering biomechanically and biologically functional soft tissues10.1021/acsami.7b08617 ↗
74. Spatially heterogeneous tubular scaffolds for in situ heart valve tissue engineering using melt electrowriting10.1002/adfm.202110716 ↗
75. Highly compliant biomimetic scaffolds for small diameter tissue-engineered vascular grafts (TEVGs) produced via melt electrowriting (MEW)
76. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring10.1016/j.biomaterials.2010.09.019 ↗
77. Whelton · 2018
78. Tubular fibrous scaffolds functionalized with Tropoelastin as a small-diameter vascular graft10.1021/acs.biomac.0c00599 ↗
79. Tissue-engineered vascular grafts with advanced mechanical strength from human iPSCs10.1016/j.stem.2019.12.012 ↗
80. Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue10.1073/pnas.0711217105 ↗
81. Effect of pulse rate on collagen deposition in the tissue-engineered blood vessel10.1089/107632703768247287 ↗
82. Humacyte Incorporated · 2022
83. Allogeneic human tissue-engineered blood vessel
84. Advancements in the fabrication technologies and biomaterials for small diameter vascular grafts: a fine-tuning of physicochemical and biological properties
85. The mechanical characterization of blood vessels and their substitutes in the continuous quest for physiological-relevant performances. A critical review
86. Elastin biosynthesis: the missing link in tissue-engineered blood vessels10.1016/j.cardiores.2006.02.021 ↗
87. Fabricating organized elastin in vascular grafts10.1016/j.tibtech.2020.09.003 ↗
88. Enhanced elastin synthesis and maturation in human vascular smooth muscle tissue derived from induced-pluripotent stem cells10.1016/j.actbio.2017.01.083 ↗
89. Pro-elastogenic effects of bone marrow mesenchymal stem cell-derived smooth muscle cells on cultured aneurysmal smooth muscle cells10.1002/term.1964 ↗
90. Fibronectin promotes elastin deposition, elasticity and mechanical strength in cellularised collagen-based scaffolds10.1016/j.biomaterials.2018.07.013 ↗
91. Transforming growth factor Beta 1 and Hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells10.1089/ten.tea.2008.0040 ↗
92. Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery10.1089/ten.tea.2013.0550 ↗
93. Arterial reconstruction with human bioengineered acellular blood vessels in patients with peripheral arterial disease10.1016/j.jvs.2019.11.056 ↗
94. Bioengineered human blood vessels10.1126/science.aaw8682 ↗
95. Biomimetic vascular grafts with circumferentially and axially oriented microporous structures for native blood vessel regeneration
96. Human fibroblast-derived ECM as a scaffold for vascular tissue engineering10.1016/j.biomaterials.2012.09.015 ↗
97. Design and comprehensive assessment of a biomimetic tri-layer tubular scaffold via biodegradable polymers for vascular tissue engineering applications10.1016/j.msec.2020.110717 ↗
98. Decellularized tissue-engineered blood vessel as an arterial conduit10.1073/pnas.1019506108 ↗
99. Influence of culture medium on smooth muscle cell differentiation from human bone marrow-derived mesenchymal stem cells10.1089/ten.tea.2008.0161 ↗
100. Performance of marrow stromal cell-seeded small-caliber multilayered vascular graft in a senescent sheep model